FlowView news

Stay up to date with our innovations, partnerships, and research highlights

A single red ball among many white balls.

Press Release

FlowView joins the EU RESOLVE project!

Collaboration with IT service provider Vitas

Introducing Asudes, our upcoming software platform revolutionizing blood analysis. It automates the detection of cancer cells, viruses, bacteria, and more while prioritizing patient data security.

Automating Blood Analysis: FlowView Diagnostics' Vision

FlowView automates blood analysis through a partnership between Radboud University and UMC Utrecht, eliminating manual processes to reshape patient outcomes.

"As an entrepreneur you have to create the opportunities yourself"

Ton van den Hoven has over 30 years in MedTech & Life Sciences. In 2023, his company, FlowView Diagnostics, plans to enter the market.

FlowView Diagnostics news! We raised €875,000 for further development.

FlowView Diagnostics from Heerenveen receives an investment of 875,000 euros from a consortium of investors, including the NOM and the Steppingstone Fund.

Top 70 Health Diagnostics Startups in the Netherlands (2021)

FlowView was recognised among the top health diagnostics startups in the Netherlands, driven by its AI solutions for cancer cell detection and infectious disease analysis.